FindTrial
Sign In

To observe the efficacy of oral fluconazole versus 5% amrolfine nail lacquer in the patients of Onychomycosis.

A Comparative Study of Efficacy and Safety of Oral Fluconazole Versus 5% Amrolfine Nail Lacquer in Patients of Onychomycosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029904
Enrollment
54
Registered
2020-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L609- Nail disorder, unspecified

Interventions

Intervention1: 5% Amrolfine nail lacquer : One group will be given 5% amrolfine nail lacquer topical once per week for 24 wks. Control Intervention1: Tab. Fluconazole: One group will be given Tab. fl

Sponsors

Dr Ruchir M Bhatt
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with any age. Patients suffering from at least one Toenail onychomycosis with or without matrix involvement.

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Suffering from other nail conditions (e.g., psoriasis) which might interfere in the interpretation of results Those on treatment with a topical or systemic antifungal during 4 weeks preceding screening. with cardiac, hepatic, or renal comorbidities those having history of hypersensitivity to any of the drugs

Design outcomes

Primary

MeasureTime frame
To determine more efficient treatment between fluconazole and amrolfine.Timepoint: At Baseline, at 12 weeks, at 24 weeks—

Secondary

MeasureTime frame
to observe most common mycological species in onychomycosisTimepoint: 24 weeks—

Countries

India

Contacts

Public ContactDr Ruchir M Bhatt

Department of Dermatology, Sir T Hospital, Bhavnagar

drbhaveshastik77@gmail.com9426039493

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026